GlaxoSmithKline Consumer Nigeria plc is holding an Annual General Meeting with the following details:

AGM date:23/05/2019
Year ended:31/12/2018
Venue::MUSON Centre, Lagos, NG
Time::10:00

About the company

Glaxosmithkline Consumer Nigeria Plc manufactures and markets a range of consumer healthcare and pharmaceutical products in Nigeria. Its product portfolio includes treatments for asthma, HIV/AIDS, malaria, depression, migraines, diabetes, heart failure, digestive ailments and cancer. Consumer healthcare products include oral healthcare products; wellness products for the management of pain, gastro-intestinal and respiratory conditions; multivitamins; and a range of nutritional healthcare beverages. Glaxosmithkline Consumer Nigeria Plc produces a range of antibacterial products and vaccines to protect against illnesses such as hepatitis A and B, diphtheria, tetanus, whooping cough, typhoid, influenza and cervical cancer. The company was formerly known as Beecham Limited. Its head office is in Lagos, Nigeria.

This annual general meeting (AGM) is a mandatory yearly gathering of the company’s interested shareholders. At the AGM, the directors of this company present an annual report containing information for shareholders about the company’s performance and strategy. Shareholders with voting rights vote on current issues, such as appointments to the company’s board of directors, executive compensation, dividend payments and selection of auditors.

To receive this company’s annual report, sign up to the investor mailing list or click on the company profile above.